Conference abstract
Activity of doxorubicin against Leishmania tropica
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: The aim of this study was to evaluate the activity of doxorubicin (Known antitumor agent, topoisomerase Ð?Ð? poison) against cutaneous leishmaniasis caused by Leishmania tropica in vitro and in vivo, in view of the developmental resistance against pentavalent antimonials. Methods: ELISA technique and in vitro model of leishmania infection were used to evaluate the potency of doxorubicin against promastigotes and intracellular amastigotes, respectively. In addition, in vivo model of leishmania infection was used to evaluate the efficacy of doxorubicin in curing the cutaneous lesions in mice. Results: The potency of doxorubicin was identified with IC50 value of (4.25±0.2 μM) against Leishmania tropica promastigotes after in vitro incubation at 26Ë?C for 48 hours. Doxorubicin was identified as active against Leishmania tropica intracellular amastigotes in peritoneal BALB/c mice macrophages with IC50 value of (3.34±0.2 μM) after incubation at 37Ë?C with 5% CO2 for 48 hours. In addition, doxorubicin was strongly effective in eradicating cutaneous lesions in the left feet of BALB/c mice previously infected by Leishmania tropica promastigotes. After 24 hours and 4 weeks of single peritoneal dose, the difference in diameters between infected feet and healthy feet was reduced to (0.018±0.008 mm), compared with untreated control mice (Pvalues: 2.6Ã?10-5 and 9.8Ã?10-8, respectively). Interferon-gamma was 287.9±23.4 pg/mL in treated serum mice after one week of single peritoneal dose (Pvalue= 9.2Ã?10-7), compared with untreated control mice. Conclusion: Our study demonstrates that doxorubicin may be a promising, effective and safe management of cutaneous leishmaniasis caused by Leishmania tropica by single dose with no relapse or unpleasant cytotoxic side effects.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Microbial & Biochemical Technology
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Ahmad Alali”
- BylineArticles whose byline prints “Mohammad Maarouf”
